Open Access<p>Effect of Dose Adjustments on the Safety and Efficacy of Afatinib in Chinese Patients with <em>EGFR</em>-Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial Program</p>
Author(s) -
HaiYan Tu,
YiLong Wu
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s273866
Subject(s) - afatinib , medicine , lung cancer , oncology , pharmacology , cancer research , epidermal growth factor receptor , erlotinib , cancer